For the flow cytometry profiling, there were some trends among the APS-1 patients of increased frequencies of the inhibitory receptor CTLA-4, and decreased frequencies of HELIOS and CD31 expressing cells. This evidence concerns the gene PECAM1 and autoimmune polyendocrine syndrome type 1.